Recent guidelines are designed to optimize uveitis screening protocols for pediatric patients.
Whatever strategy you employ to encourage vaccinations, it is important to be respectful and empathize with your patient’s concerns and perspectives.
Colleen P. Halfpenny, MD, (Wills Eye) Tania Tai, MD, (New York Eye and Ear) and Vaidehi Dedania, MD, (NYU) all weigh in on how the prospect of rho-kinase inhibitors are primed to change pharmaceutical eye care from the retina to the cornea.
Glaucoma specialists Noureen Khan, MD, of Northern Virginia Ophthalmology Associates, P.C., and Monisha Vora, MD, of Wills Eye Hospital, discuss how to spot and manage MIGS complications, and how to avoid them in the first place.
Telemedicine offers new possibilities in the diagnosis and follow-up care of ocular surface diseases.
With new technologies and techniques, research is offering new ways to revive vision loss from retinal damage and disease.
A growing body of research shows SLT for first-line glaucoma therapy works as well as drops — so why aren’t clinician’s embracing it?